BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee GH, Phyo WW, Loo WM, Kwok R, Ahmed T, Shabbir A, So J, Koh CJ, Hartono JL, Muthiah M, Lim K, Tan PS, Lee YM, Lim SG, Dan YY. Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population. World J Hepatol 2020; 12(12): 1228-1238 [PMID: 33442450 DOI: 10.4254/wjh.v12.i12.1228]
URL: https://www.wjgnet.com/1948-5182/full/v12/i12/1228.htm
Number Citing Articles
1
Shenling Liao, Kang An, Zhi Liu, He He, Zhenmei An, Qiaoli Su, Shuangqing Li. Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western ChinaJournal of Clinical Laboratory Analysis 2022; 36(9) doi: 10.1002/jcla.24626
2
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini ReviewBiomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
3
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G. Vari, Aleksandr Kamyshnyi. Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisViruses 2023; 15(8): 1724 doi: 10.3390/v15081724
4
Limin Cao, Yu An, Huiyuan Liu, Jinguo Jiang, Wenqi Liu, Yuhan Zhou, Mengyuan Shi, Wei Dai, Yanling Lv, Yuhong Zhao, Yanhui Lu, Liangkai Chen, Yang Xia. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysisBMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03315-0
5
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, Mohammadreza Kasravi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approachesEuropean Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01708-8
6
You Wu, Zhicong Zhao, Xia Deng, Jue Jia, Guoyue Yuan. Pregnancy zone protein, a potential research target in multiple diseasesGene 2025; 935: 149013 doi: 10.1016/j.gene.2024.149013
7
Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee. From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?Clinical and Molecular Hepatology 2021; 27(2): 257 doi: 10.3350/cmh.2021.0067
8
Karla Sawada Toda-Oti, José Tadeu Stefano, Ana Mercedes Cavaleiro, Flair José Carrilho, Maria Lúcia Correa-Gianella, Cláudia Pinto Marques de Souza de Oliveira. Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian PatientsMetabolic Syndrome and Related Disorders 2022; 20(2): 114 doi: 10.1089/met.2020.0104
9
Michael Sun, Vincent J Yao, Aivi A Rahman, Kevin Liu, Saud Rehman, Amber Sun, Alan C Yao. Serum Creatinine as an Independent Predictor of Moderate to Severe Fibrosis in Chinese American Non-obese Metabolic Dysfunction-Associated Steatotic Liver DiseaseCureus 2024;  doi: 10.7759/cureus.61116
10
Eda Kaya, Yusuf Yilmaz. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the LiverJournal of Clinical and Translational Hepatology 2022; 10(2): 329 doi: 10.14218/JCTH.2021.00178